Journals
Consult the user guide
For assistance, please contact us
Consult the user guide
For assistance, please contact us
Add search criteria
Results: 1 - 15 of 24
2015-06-17 [p.2813]
Mr. Cannan (Kelowna—Lake Country), from the Standing Committee on International Trade, presented the Fifth Report of the Committee, "Connecting Canadian Companies to International Markets: The Global Markets Action Plan and Small and Medium-Sized Enterprises". — Sessional Paper No. 8510-412-276.
Pursuant to Standing Order 109, the Committee requested that the government table a comprehensive response.
A copy of the relevant Minutes of Proceedings (Meetings Nos. 27 to 29, 31 and 43 to 60) was tabled.
2015-06-10 [p.2695]
— Nos. 412-5443 and 412-5444 concerning international trade. — Sessional Paper No. 8545-412-92-04;
2015-06-09 [p.2676]
— No. 412-5531 concerning the protection of the environment. — Sessional Paper No. 8545-412-2-39;
2015-05-05 [p.2472]
— by Mr. Davies (Vancouver Kingsway), one concerning the protection of the environment (No. 412-5531).
2015-04-27 [p.2422]
— by Mr. Valeriote (Guelph), two concerning international trade (Nos. 412-5443 and 412-5444);
2015-04-01 [p.2335]
— Nos. 412-4931 to 412-4933 concerning the protection of the environment. — Sessional Paper No. 8545-412-2-32;
2015-03-25 [p.2279]
Pursuant to Standing Order 32(2), Mr. Anderson (Parliamentary Secretary to the Minister of Foreign Affairs and Consular) laid upon the Table, — Copy of the Amendments to Annex III of the Rotterdam Convention on the Prior Informed Consent Procedure for Certain Hazardous Chemicals and Pesticides in International Trade, and Explanatory Memorandum, dated April 28 to May 10, 2013. — Sessional Paper No. 8532-412-48.
2015-02-17 [p.2138]
— by Mr. Davies (Vancouver Kingsway), two concerning the issuing of visas (Nos. 412-4929 and 412-4930), three concerning the protection of the environment (Nos. 412-4931 to 412-4933) and one concerning climate change (No. 412-4934);
2015-01-26 [p.2009]
Q-884 — Ms. Freeland (Toronto Centre) — With regard to the government's Global Markets Action Plan (GMAP): (a) what submissions, proposals or recommendations were made by stakeholders during the consultation process; (b) what are the dates, times and locations of the meetings with those individuals or organizations consulted during the creation of GMAP; (c) what is the total of all government expenditures related to the consultation process related to GMAP, including, but not limited to, (i) travel expenses, including transportation, accommodation, rental meeting spaces or equipment, food and other travel-related expenses, (ii) staff time costs, including any overtime pay incurred, (iii) any services or other support procured from consultants or other contractors, (iv) other relevant expenses incurred, broken down by all related details; (d) what are the titles and file names of all reports, emails and briefing notes prepared in relation to the development and consultation process involved in the creation of GMAP? — Sessional Paper No. 8555-412-884.
2015-01-26 [p.2010]
Q-888 — Ms. Davies (Vancouver East) — With regard to Health Canada: for the last ten years, (a) how many drug safety inspectors has Health Canada employed, broken down by year; (b) how many inspections of pharmaceutical manufacturing companies has Health Canada conducted within Canada, broken down by year; (c) how many pharmaceutical manufacturing companies inspected within Canada have received a warning letter or citation from Health Canada, broken down by year; (d) how many pharmaceutical manufacturing companies inspected within Canada have had penalties imposed, broken down by year; (e) how many pharmaceutical manufacturing companies inspected within Canada have been subject to a ban, broken down by year; (f) how many inspections of pharmaceutical manufacturing companies has Health Canada conducted internationally, broken down by year; (g) how many pharmaceutical manufacturing companies inspected internationally have received a warning letter or citation from Health Canada, broken down by year; (h) how many pharmaceutical manufacturing companies inspected internationally have had penalties imposed, broken down by year; (i) how many pharmaceutical manufacturing companies inspected internationally have been subject to a ban, broken down by year; (j) how many notices of violation concerning companies operating in Canada has Health Canada received from foreign regulators, broken down by year; (k) how many pharmaceutical manufacturing companies has Health Canada inspected because of a notification received from a foreign regulator, broken down by year; (l) how many clinical trials has Health Canada inspected, broken down by year; (m) how many clinical trials received a warning letter or citation from Health Canada following an inspection, broken down by year; (n) how many clinical trials have been shut down by Health Canada following an inspection, broken down by year; (o) how many investigations has Health Canada conducted regarding promotion of off-label prescription of drugs by pharmaceutical companies, broken down by year; (p) how many fines or penalties has Health Canada levied for off-label promotions, broken down by year; (q) how many reports of side effects relating to off-label prescriptions of pharmaceuticals has Health Canada received, broken down by year; and (r) when will Health Canada begin including side effects related to off-label prescriptions in its public database? — Sessional Paper No. 8555-412-888.
2015-01-26 [p.2019]
Q-913 — Mr. Easter (Malpeque) — With regard to international trade, respecting the Canada-European Union Summit in Ottawa and Toronto on September 25 and 26, 2014: what are the details of all contracts for goods or services relating to the summit, providing for each contract: (i) the name of the contractor, (ii) a description of the goods or services provided, (iii) the value of the contract, (iv) whether or not there was an open bidding process for the contract? — Sessional Paper No. 8555-412-913.
2015-01-26 [p.2020]
Q-914 — Ms. Sgro (York West) — With regard to international trade, respecting the Canada-European Union Summit in Ottawa and Toronto on September 25 and 26, 2014: (a) what were the expenses incurred in relation to travel by government officials from the current Department of Foreign Affairs, Trade and Development to Ottawa, or to any European location, specifying the location, broken down by (i) department, (ii) individual incurring the expense, (iii) details of the expense; and (b) what were the expenses incurred in Ottawa and in Toronto in relation to all receptions, press conferences, signing ceremonies, official meetings, or bilateral meetings, for Canadian and European officials broken down by (i) department, (ii) individual incurring the expense, (iii) details of the expense? — Sessional Paper No. 8555-412-914.
2015-01-26 [p.2020]
Q-916 — Mr. Garneau (Westmount—Ville-Marie) — With regard to foreign affairs: (a) what are the dates, locations, and attendees of all meetings held from March 1, 2010, to December 4, 2014, attended by the Minister of Foreign Affairs, his staff, or officials from his Department, concerning the Global Market Action Plan; and (b) for all briefing materials or documents prepared for the Minister, his staff, or officials relative to such meetings, whether prepared before or after the meeting, what is (i) the date of the document, (ii) the title or subject matter of the document, (iii) the Department’s internal tracking number? — Sessional Paper No. 8555-412-916.
2015-01-26 [p.2020]
Q-917 — Ms. Sgro (York West) — With regard to international trade: (a) what are the dates, locations, and attendees of all meetings held from March 1, 2010, to December 4, 2014, attended by the Minister of International Trade, his staff, or officials from his Department, concerning the 2014 Corporate Social Responsibility Strategy; and (b) for all briefing materials or documents prepared for the Minister, his staff, or officials relative to such meetings, whether prepared before or after the meeting, what is (i) the date of the document, (ii) the title or subject matter of the document, (iii) the Department’s internal tracking number? — Sessional Paper No. 8555-412-917.
2014-11-05 [p.1731]
Q-680 — Mr. Mai (Brossard—La Prairie) — With regard to the transshipment of an endangered fin whale from Iceland to Japan through Canada: (a) is the government committed to stand against the illegal trade of endangered wildlife; (b) when were the following departments first notified of this transshipment, (i) Canada Border Services Agency, (ii) Fisheries and Oceans Canada, (iii) Environment Canada, (iv) Foreign Affairs, Trade and Development Canada, (v) Canadian Food Inspection Agency; (c) what actions did the following departments undertake after being notified, (i) Canada Border Services Agency, (ii) Fisheries and Oceans Canada, (iii) Environment Canada, (iv) Foreign Affairs, Trade and Development Canada, (v) Canadian Food Inspection Agency; (d) what steps is the government taking to ensure that this transshipment of endangered species across Canada does not happen again; (e) did Environment Canada’s Wildlife Enforcement Directorate raise any concerns regarding this shipment, (i) if so, what were they, (ii) if not, why not; (f) has the government examined the appropriateness of this shipment in light of the Wild Animal and Plant Protection and Regulation of International and Interprovincial Trade Act; and (g) has the government considered following the example put forward by the United States by banning the transit of meat from endangered fin whales or any endangered species under the Convention on International Trade in Endangered Species of Wild Fauna and Flora? — Sessional Paper No. 8555-412-680.
Results: 1 - 15 of 24 | Page: 1 of 2

1
2
>
>|
Export As: XML CSV RSS

For more data options, please see Open Data